Anti-(insulin Receptor) Monoclonal Antibody-stimulated Tyrosine Phosphorylation in Cells Transfected with Human Insulin Receptor CDNA
Overview
Affiliations
The effects of insulin and anti-(insulin receptor) monoclonal antibodies on tyrosine phosphorylation were investigated in fibroblasts transfected with human insulin receptor cDNA (NIH 3T3HIR3.5 cells) using anti-phosphotyrosine immunoblotting. Insulin increased levels of tyrosine phosphorylation in two major proteins of molecular mass 97 kDa (pp97, assumed to be the insulin receptor beta-subunit) and 185 kDa (pp185). Insulin-mimetic anti-receptor antibodies also stimulated tyrosine phosphorylation of both pp97 and pp185. The observation of antibody-stimulated pp97 phosphorylation, as detected by immunoblotting, is in contrast with previous data which failed to show receptor autophosphorylation in NIH 3T3HIR3.5 cells labelled with [32P]P1. The effect of insulin on pp97 was maximal within 1 min, but the response to antibody was apparent only after a lag of 1-2 min and rose steadily over 20 min. The absolute level of antibody-stimulated phosphorylation of both pp97 and pp185 after 20 min was only about 20% of the maximum level induced by equivalent concentrations of insulin, even at concentrations of antibody sufficient for full occupancy of receptors. Another insulin-mimetic agent, wheat-germ agglutinin, stimulated receptor autophosphorylation with kinetics similar to those produced by the antibody. It is suggested that the relatively slow responses to both agents may be a function of the dependence on receptor cross-linking. These data are consistent with a role for the insulin receptor tyrosine kinase activity in the mechanism of action of insulin-mimetic anti-receptor antibodies.
Brierley G, Siddle K, Semple R Diabetologia. 2018; 61(7):1662-1675.
PMID: 29700562 PMC: 6445487. DOI: 10.1007/s00125-018-4606-2.
Huang C, Hao L, Buetow D Mol Cell Biochem. 2002; 233(1-2):65-72.
PMID: 12083381 DOI: 10.1023/a:1015514324328.
Newby A, Lim K, Evans M, Brindle N, Booth R Br J Pharmacol. 1995; 114(8):1652-6.
PMID: 7599935 PMC: 1510373. DOI: 10.1111/j.1476-5381.1995.tb14953.x.
Lloyds D, Brindle N, Hallett M Immunology. 1995; 84(2):220-6.
PMID: 7538489 PMC: 1415090.